600488 津药药业
2025/09 - 九个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)2.2874.4403.9501.1871.626
总资产报酬率 ROA (%)1.2162.2541.8300.5450.777
投入资产回报率 ROIC (%)1.7993.3702.6530.7621.075

边际利润分析
销售毛利率 (%)40.76145.44546.42549.07347.634
营业利润率 (%)8.8027.0154.4781.9033.890
息税前利润/营业总收入 (%)6.1277.2924.9021.1325.183
净利润/营业总收入 (%)5.0326.4764.3000.5002.899

收益指标分析
经营活动净收益/利润总额(%)170.623122.907114.5091,621.443122.055
价值变动净收益/利润总额(%)0.678-4.014-0.669-179.2553.344
营业外收支净额/利润总额(%)-53.2450.423-0.694-460.9192.169

偿债能力分析
流动比率 (X)1.7361.4851.0861.0350.930
速动比率 (X)1.1940.9490.7130.5280.448
资产负债率 (%)32.19231.80638.89643.55739.845
带息债务/全部投入资本 (%)18.74815.28023.92133.61731.612
股东权益/带息债务 (%)411.515524.793300.551187.495206.843
股东权益/负债合计 (%)163.513168.688123.622102.611118.388
利息保障倍数 (X)15.98629.55210.7751.4284.295

营运能力分析
应收账款周转天数 (天)51.86740.37436.73941.14442.241
存货周转天数 (天)130.234141.355167.252204.385190.760